Ackman takes 5% stake in Valeant

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Mar 9, 2015 at 12:50 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Valeant stock spiked today on news that Bill Ackman's Pershing Square has taken a 5% stake in Valeant.
     

  2. Anonymous

    Anonymous Guest

    This is huge. Ackman only invests in strong companies- and if the company isn't performing he steps in and makes changes! He has strong confidence in our company though. We are going to be one of the largest pharmaceutical companies (if not THE largest) within 10 years- bank on it!!!
     
  3. Anonymous

    Anonymous Guest

    Huge? Maybe. Or he could be playing us like he played Allergen. Team up with someone else to put an offer on Valeant. Then cash out. Why else would he invest in a company that keeps racking up debt? Pearson has drifted off strategy with the latest two offerings.
     
  4. Anonymous

    Anonymous Guest

    Salix is looking like a horrible buy. Have you read the Salix board? Talk about employees that aren't going to last! On top of that we bought a company that has shit financials and no pipeline.

    He better find some big time cost cuts or he this is going to be a disaster for 11 billion!
     
  5. Anonymous

    Anonymous Guest

    no pipeline? You are the moron. Our pipeline for rifaximin is 5 billion a year alone. It has a patent until 2029. You will be fired long before I ever will.

    As far as our board, we have some serious whiners. But have you ever looked at your board? Our people are scared, what is your excuse?
     
  6. Anonymous

    Anonymous Guest

    Yes, this response to the OP is realistic. Pipeline for Rifaximin is, in fact, quite strong. This had to be one of the key factors in the acquisition of Salix.
     
  7. Anonymous

    Anonymous Guest

    Ackman took advantage of our CEO once to benefit his own company, he is now seizing the opportunity to do it again. Change will come quickly once Ackman has his plan in place.
     
  8. Anonymous

    Anonymous Guest

    Rifaxamin will NEVER do anywhere close to 5 billion a year. haha you guys are stupid.
     
  9. Anonymous

    Anonymous Guest

    Ackman must have a plan. Who knows but he is smart and not afraid
     
  10. Anonymous

    Anonymous Guest

    My bet is a big break up of the company. Seems ridiculous but once all of the people are laid off from the various product lines others will buy the products and what is left of the companies.

    Valeant is worth more in parts sold to others than it is as a whole company.
     
  11. Anonymous

    Anonymous Guest

    That would be interesting
     
  12. Anonymous

    Anonymous Guest

    Completely wrong. Biggest benefit to Valeant is tax rate. Breaking it up likely destroys that in asset sales. Every buyer wild be overpaying if their tax rate was higher than combined Valeant tax rate. And assets aren't attractive to most companies.
     
  13. Anonymous

    Anonymous Guest

    No company is perfect ; takeovers can usually wring out more value
     
  14. Anonymous

    Anonymous Guest

    Ackman knows where and his to wring value